Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study
Crossref DOI link: https://doi.org/10.1007/s11523-014-0320-2
Published Online: 2014-06-15
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brana, Irene
Calles, Antonio
LoRusso, Patricia M.
Yee, Lorrin K.
Puchalski, Thomas A.
Seetharam, Shobha
Zhong, Bob
de Boer, Carla J.
Tabernero, Josep
Calvo, Emiliano
Text and Data Mining valid from 2014-06-15